część 1

SZPITAL UNIWERSYTECKI W KRAKOWIE

Published: Mar 11, 2026

Updated: May 6, 2026

Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Takeda Pharma Sp. z o. o.; ASCLEPIOS S.A.; Janssen-Cilag Polska Sp. z o.o.; Salus International Sp. z o.o.; Astellas Pharma Sp. z o.o. — PLN 14,319,732

Browse open Health & Medical tenders in Poland

About This Opportunity

część 1 — supply contract awarded in Poland by Szpital Uniwersytecki W Krakowie. Awarded to Takeda Pharma Sp. z o. o (PLN 14.3M, Feb 2026).

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of PLN 6.9 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

This tender, originating from Poland and published via the TED (Tenders Electronic Daily) platform, seeks the procurement of a critical pharmaceutical product. The primary focus of this procurement is Brentuximab vedotinum, with a specified quantity of 600 units. This represents a direct supply contract for a targeted medication, likely intended for patient treatment within the Polish healthcare system.

The contracting authority, managed by the Publications Office of the European Union, is initiating this process to ensure a reliable and timely supply of this essential drug. Typical requirements for such tenders would encompass adherence to stringent quality standards, including compliance with Good Manufacturing Practices (GMP) and relevant pharmaceutical regulations set forth by Polish and European authorities. Bidders are generally expected to demonstrate robust supply chain management capabilities, ensuring product integrity from manufacturing to delivery. Furthermore, experience in handling and distributing specialized oncology medications, along with the provision of necessary documentation such as Certificates of Analysis and batch traceability records, will be crucial. The tender will likely assess the financial stability and technical expertise of prospective suppliers to guarantee consistent availability and quality of Brentuximab vedotinum.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 11, 2026. Last refreshed 50 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About SZPITAL UNIWERSYTECKI W KRAKOWIE

SZPITAL UNIWERSYTECKI W KRAKOWIE has issued 245 procurement notices on BidsFactory, including 35 currently open and 100 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: June 19, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Takeda Pharma Sp. z o. o.; ASCLEPIOS S.A.; Janssen-Cilag Polska Sp. z o.o.; Salus International Sp. z o.o.; Astellas Pharma Sp. z o.o. was awarded the contract for PLN 14,319,732. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Takeda Pharma Sp. z o. o.; ASCLEPIOS S.A.; Janssen-Cilag Polska Sp. z o.o.; Salus International Sp. z o.o.; Astellas Pharma Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by SZPITAL UNIWERSYTECKI W KRAKOWIE in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.